Skip to main content
. 2013 May 30;4:62. doi: 10.3389/fendo.2013.00062

Table 1.

Characteristicsa of women by diabetes status.

Non-DM Prevalent DM p-Value
(N = 6458) (N = 409)
Age (years) 70.7 ± 4.7 71.0 ± 4.6 0.35
Weight (kg) 67.1 ± 12.0 72.6 ± 14.8 <0.001
Change in weight (V6-BL) (%/year) −0.25 ± 0.96 −0.41 ± 0.99 0.012
Height (cm) 159.6 ± 5.9 158.9 ± 6.1 0.017
Height loss since age 25 (cm) 3.1 ± 2.8 2.9 ± 2.6 0.095
Years since menopause (years) 23.6 ± 7.8 24.7 ± 8.1 0.006
Current smoker 573 (8.9) 34 (8.3) 0.69
Current vitamin D use 2958 (46.6) 149 (36.9) <0.001
Current calcium use 2871 (44.6) 134 (32.8) <0.001
Current estrogen use 1226 (19.5) 42 (10.4) <0.001
Alendronate taken in last 2 years (V6) 479 (8.9) 18 (6.6) 0.18
Current raloxifene use (V6) 8 (0.2) 1 (0.4) 0.36
Current thiazide use 1513 (23.7) 153 (37.8) <0.001
Current statin use (V4) 248 (3.9) 22 (5.5) 0.12
Current oral steroid use 110 (1.7) 4 (1.0) 0.27
Grip strength (kg) 21.3 ± 4.1 20.8 ± 4.4 0.020
Walking speed (m/s) 1.05 ± 0.20 0.96 ± 0.21 <0.001
Inability to rise from chair 142 (2.2) 14 (3.4) 0.10
Walk for exercise 3478 (53.9) 189 (46.2) 0.003
Poor light touch discrimination (V2) 240 (4.3) 35 (9.9) <0.001
Baseline BMD
Calcaneus BMD (g/cm2) 0.41 ± 0.09 0.44 ± 0.10 <0.001
Distal radius BMD (g/cm2) 0.36 ± 0.08 0.39 ± 0.08 <0.001
Proximal radius BMD (g/cm2) 0.64 ± 0.1 0.67 ± 0.1 <0.001
Femoral neck BMD (V2) (g/cm2) 0.65 ± 0.11 0.69 ± 0.12 <0.001
Total hip BMD (V2) (g/cm2) 0.76 ± 0.13 0.81 ± 0.14 <0.001
Total lumbar spine BMD (V2) (g/cm2) 0.86 ± 0.17 0.9 ± 0.17 <0.001

Mean (SD), or N (%). BMD, bone mineral density; DM, diabetes mellitus.

aMeasurement at baseline visit unless otherwise indicated.